Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1690539rdf:typepubmed:Citationlld:pubmed
pubmed-article:1690539lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0010798lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0243102lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:1690539lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:1690539pubmed:issue2lld:pubmed
pubmed-article:1690539pubmed:dateCreated1990-4-26lld:pubmed
pubmed-article:1690539pubmed:abstractTextAn anti-peptide antibody has been produced which binds to and specifically inhibits the activity of cytochrome P-450IA2 in rat hepatic microsomes. This was achieved by raising an antibody against a synthetic peptide (Ser-Glu-Asn-Tyr-Lys-Asp-Asn), the sequence of which occurs in cytochrome P-450IA2 at positions 290-296. The selection of this region of cytochrome P-450IA2 was based on several criteria, including prediction of surface and loop areas, identification of variable regions between cytochromes P-450IA2 and P-450IA1, and consideration of a site on cytochrome P-450IA1 where chemical modification has been shown to cause substantial enzyme inactivation. The specificity of antibody binding was determined by enzyme-linked immunosorbent assay and by immunoblotting using hepatic microsomal preparations and purified cytochrome P-450 isoenzymes. This showed that the antibody binds specifically to rat and mouse cytochrome P-450IA2 and to no other cytochrome P-450, as was predicted from the amino acid sequences of the peptide and the cytochromes P-450. The effect of the antibody upon enzyme activity was studied in hepatic microsomes from rats treated with 3-methylcholanthrene. The antibody was shown to inhibit specifically the activity of reactions catalysed by cytochrome P-450IA2 (phenacetin O-de-ethylase and 2-acetylaminofluorene activation), but had no effect on aryl hydrocarbon hydroxylase activity, which is catalysed by cytochrome P-450IA1, or on aflatoxin B1 activation.lld:pubmed
pubmed-article:1690539pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:languageenglld:pubmed
pubmed-article:1690539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:citationSubsetIMlld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690539pubmed:statusMEDLINElld:pubmed
pubmed-article:1690539pubmed:monthMarlld:pubmed
pubmed-article:1690539pubmed:issn0264-6021lld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:BoobisA RARlld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:DaviesD SDSlld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:EdwardsR JRJlld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:MurrayB PBPlld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:SesardicDDlld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:SingletonA...lld:pubmed
pubmed-article:1690539pubmed:authorpubmed-author:RichK JKJlld:pubmed
pubmed-article:1690539pubmed:issnTypePrintlld:pubmed
pubmed-article:1690539pubmed:day1lld:pubmed
pubmed-article:1690539pubmed:volume266lld:pubmed
pubmed-article:1690539pubmed:ownerNLMlld:pubmed
pubmed-article:1690539pubmed:authorsCompleteYlld:pubmed
pubmed-article:1690539pubmed:pagination497-504lld:pubmed
pubmed-article:1690539pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
pubmed-article:1690539pubmed:meshHeadingpubmed-meshheading:1690539-...lld:pubmed
More...